A Four-kallikrein Panel and ?-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer.

M Assel; T Visakorpi; TL Tammela; H Lilja; L Sjöblom; TJ Murtola; K Talala; P Kujala; UH Stenman; K Taari; A Auvinen; A Vickers

doi:10.1016/j.euf.2017.11.002

A Four-kallikrein Panel and ?-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer.

M Assel, T Visakorpi, TL Tammela, H Lilja, L Sjöblom, TJ Murtola, K Talala, P Kujala, UH Stenman, K Taari, A Auvinen, A Vickers

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

8 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Julkaisu	European Urology Focus
DOI - pysyväislinkit	https://doi.org/10.1016/j.euf.2017.11.002
Tila	Julkaistu - 2017
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Tutkimusalat

4Kscore
Beta-microseminoprotein
Eturauhassyöpä
Kallikriens
Prediction models
Prostate Cancer
Screening
ennusmallit
kallikreiinit
seulonta

Julkaisufoorumi-taso

Jufo-taso 1

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

Pääsy asiakirjaan

10.1016/j.euf.2017.11.002

http://urn.fi/URN:NBN:fi:tuni-202001161343

Siteeraa tätä

Assel, M., Visakorpi, T., Tammela, TL., Lilja, H., Sjöblom, L., Murtola, TJ., Talala, K., Kujala, P., Stenman, UH., Taari, K., Auvinen, A., & Vickers, A. (2017). A Four-kallikrein Panel and ?-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer. European Urology Focus. https://doi.org/10.1016/j.euf.2017.11.002

@article{b8fe5ed85eb84424815cc8a33769adee,

title = "A Four-kallikrein Panel and ?-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer.",

keywords = "4Kscore, Beta-microseminoprotein, Eturauhassy{\"o}p{\"a}, Kallikriens, Prediction models, Prostate Cancer, Screening, ennusmallit, kallikreiinit, seulonta, 4Kscore, Beta-microseminoprotein, Eturauhassy{\"o}p{\"a}, Kallikriens, Prediction models, Prostate Cancer, Screening, ennusmallit, kallikreiinit, seulonta",

author = "M Assel and T Visakorpi and TL Tammela and H Lilja and L Sj{\"o}blom and TJ Murtola and K Talala and P Kujala and UH Stenman and K Taari and A Auvinen and A Vickers",

year = "2017",

doi = "10.1016/j.euf.2017.11.002",

language = "English",

}

Assel, M, Visakorpi, T , Tammela, TL, Lilja, H, Sjöblom, L, Murtola, TJ, Talala, K, Kujala, P, Stenman, UH, Taari, K, Auvinen, A & Vickers, A 2017, 'A Four-kallikrein Panel and ?-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer.', European Urology Focus. https://doi.org/10.1016/j.euf.2017.11.002

TY - JOUR

T1 - A Four-kallikrein Panel and ?-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer.

AU - Assel, M

AU - Visakorpi, T

AU - Tammela, TL

AU - Lilja, H

AU - Sjöblom, L

AU - Murtola, TJ

AU - Talala, K

AU - Kujala, P

AU - Stenman, UH

AU - Taari, K

AU - Auvinen, A

AU - Vickers, A

PY - 2017

Y1 - 2017

KW - 4Kscore

KW - Beta-microseminoprotein

KW - Eturauhassyöpä

KW - Kallikriens

KW - Prediction models

KW - Prostate Cancer

KW - Screening

KW - ennusmallit

KW - kallikreiinit

KW - seulonta

KW - 4Kscore

KW - Beta-microseminoprotein

KW - Eturauhassyöpä

KW - Kallikriens

KW - Prediction models

KW - Prostate Cancer

KW - Screening

KW - ennusmallit

KW - kallikreiinit

KW - seulonta

U2 - 10.1016/j.euf.2017.11.002

DO - 10.1016/j.euf.2017.11.002

M3 - Article

SN - 2405-4569

JO - European Urology Focus

JF - European Urology Focus

ER -